When an 80-year-old arrives at a hospital emergency department, clinicians face one of the most consequential questions in modern medicine: not simply what is wrong with this patient today, but how resilient is this person overall. A new retrospective observational study from Haukeland University Hospital in Bergen, Norway, published in BMC Geriatrics, offers a strikingly data-driven answer to that question. Researchers led by Hans Flaatten of the Department of Research and Development at Haukeland University Hospital compared two complete calendar-year cohorts of patients aged 80 years and above admitted to the tertiary hospital, one from 2012 and one from 2022, and measured how a simple administrative frailty score tracked with survival, length of stay, readmission, and hospital mortality. The findings carry weight far beyond a single Norwegian institution, because they suggest that a decade of population aging has not translated into a decade of increasing frailty among the very old, even as the sheer volume of their hospital admissions has grown substantially.
The technical heart of the study is the Hospital Frailty Risk Score, or HFRS, an instrument developed to exploit data that hospitals already collect. Rather than relying on time-consuming clinical assessments, the HFRS scans a patient’s ICD-10 diagnostic codes, the standard classification system used for hospital billing and registries worldwide, and assigns points based on the presence of diagnoses statistically associated with frailty. Patients accumulate a score across their coded conditions, and the researchers classified anyone with an HFRS above 15 as frail. This approach transforms routine administrative data into a population-scale frailty screening tool, allowing investigators to stratify thousands of hospitalized patients without a single additional bedside examination. It is a technique that has gained traction internationally precisely because it is cheap, reproducible, and applicable to any hospital that codes diagnoses in ICD-10.
The scale of the comparison is itself notable. In 2012, the hospital recorded 5112 admissions among patients aged 80 and above. By 2022, that figure had climbed to 6232 admissions, an increase of more than 20 percent in a single decade, reflecting both demographic aging in the Bergen catchment area and the growing intensity of hospital use by the very old. In both cohorts, women made up the majority of admitted patients, a pattern consistent with the female predominance in advanced age populations. Yet when the researchers applied the HFRS to both cohorts, they found something unexpected: roughly half of the patients in each cohort were classified as frail, with no significant difference between 2012 and 2022 and no significant sex difference in frailty classification. The proportion of frail patients among the very old admitted to this hospital did not rise over ten years, even as the absolute number of admissions grew.
That stability in frailty prevalence is the study’s most counterintuitive result. Many observers assume that as populations age, the fraction of very old people who are frail must increase in lockstep. The Bergen data challenge that assumption. The researchers found no increase in frailty over the ten-year period in the two cohorts, suggesting that the additional patients entering the hospital in 2022 were not systematically more fragile than those admitted a decade earlier. This could reflect genuine population-level resilience, improvements in preventive care and chronic disease management, or the possibility that the HFRS, being based on diagnostic codes, captures a relatively stable administrative signature of frailty. Whatever the mechanism, the result implies that rising admission volumes among the very old are driven more by numbers than by deterioration in the population’s underlying condition.
Where the HFRS truly proved its worth was in predicting outcomes. Non-frail patients, those with an HFRS of 15 or below, had the highest one-year survival after their last admission, at 87 percent. In the high frailty group, one-year survival fell to 69 percent, an 18-percentage-point gap that persisted across the statistical analysis. Survival was analyzed using Kaplan-Meier curves, the standard non-parametric method for estimating survival over time, and Cox regression models, which allow investigators to quantify the effect of frailty on mortality while accounting for other variables. The consistency of the association between higher HFRS and worse clinical outcomes, including hospital length of stay, 30-day readmission, hospital mortality, and one-year survival, indicates that the score is not merely a statistical curiosity but a meaningful prognostic instrument.
Sex emerged as a critical modifier of frailty’s impact. Frail males had a one-year mortality of 65 percent, substantially higher than frail females, and mortality also rose sharply in the age group of 90 years and above. When the researchers combined these risk factors, the results became stark. The subgroup with high frailty risk, an HFRS above 15, combined with age of 90 years or above and male sex, had the lowest survival of all subgroups analyzed, at just 60 percent one-year survival. This finding has immediate clinical relevance: an 80-plus patient who is male, over 90, and carries a high administrative frailty score represents a population at extreme risk, and hospitals could use this simple combination to trigger enhanced discharge planning, comprehensive geriatric assessment, or closer follow-up.
The study’s methodology deserves careful attention because it exemplifies a broader trend in outcomes research. As a retrospective observational study, it compared two separate calendar-year cohorts rather than following patients prospectively, which means it can identify associations but cannot prove causation. The researchers used ordinary registry data already reported to the Norwegian Patient Registry, and the study was approved by the Regional Committee for Medical and Health Research Ethics in Western Norway, with informed consent waived because the analyses relied on existing registry records. Data handling followed hospital regulations and the Declaration of Helsinki. This registry-based design is what makes the HFRS approach so scalable: any health system with coded hospital data can replicate the analysis, and the score requires no new data collection infrastructure.
For clinicians and hospital administrators, the practical implications are layered. First, the HFRS can identify vulnerable patient groups with significantly increased mortality using nothing more than diagnostic codes, meaning frailty screening could be embedded in routine hospital operations at essentially no marginal cost. Second, the finding that half of all patients aged 80 and above admitted to a tertiary hospital are classified as frail underscores that frailty is not a marginal condition among the very old but the dominant clinical reality. Third, the stability of frailty prevalence over a decade suggests that hospitals preparing for future demand should plan for volume growth rather than assuming each new cohort of very old patients will be more fragile than the last. Fourth, the identification of the male, over-90, high-frailty subgroup as the highest-risk population gives hospitals a concrete target for intervention programs.
The Bergen study also speaks to an international conversation about how health systems should measure and respond to frailty. The HFRS was designed to be applied at scale, and its validation in a Norwegian tertiary hospital adds to growing evidence that administrative frailty scores can stratify risk in ways that align with clinical judgment. The score’s reliance on ICD-10 codes means it inherits the limitations of coded data: it may miss frailty features that are not reflected in diagnoses, and coding practices can vary between institutions and over time. Nevertheless, the association between higher HFRS and worse outcomes in this study, spanning length of stay, readmission, mortality, and one-year survival, demonstrates that the score captures a real and consequential clinical phenomenon.
As populations across Europe and North America continue to age, studies like this one provide a template for evidence-based planning. The Bergen researchers showed that a simple administrative score can separate very old hospital patients into risk strata with dramatically different survival prospects, that frailty prevalence among the very old admitted to hospital has remained stable over a decade of demographic change, and that specific combinations of frailty, age, and sex identify patients at extreme risk. The message for health systems is twofold: the very old will increasingly dominate hospital admissions, and the tools to understand their risk are already sitting in the data hospitals collect every day. Turning that data into better care for the highest-risk patients, the frail men over 90 whose one-year survival falls to 60 percent, may be one of the most actionable opportunities in geriatric medicine today.
Subject of Research: Frailty assessment and one-year survival outcomes in hospitalized patients aged 80 years and above using the Hospital Frailty Risk Score
Article Title: Frailty and outcome after hospital admissions in two populations aged 80 years and above in 2012 and 2022 using the Hospital Frailty Risk Score
Article References: Flaatten, H., Kolnes, J., Skilbrei, B., & Hodneland, E. (2026). Frailty and outcome after hospital admissions in two populations aged 80 years and above in 2012 and 2022 using the Hospital Frailty Risk Score. BMC Geriatrics. https://doi.org/10.1186/s12877-026-08385-8
Image Credits: AI Generated
DOI: 10.1186/s12877-026-08385-8
Keywords: frailty, Hospital Frailty Risk Score, geriatrics, hospital admission, one-year survival, ICD-10, Bergen Norway, elderly patients, mortality risk, Kaplan-Meier analysis, Cox regression, health outcomes
News Source: Beatrice Stafford. (October 18, 2026). Frailty Risk Score Predicts One-Year Survival in Hospitalized Patients Aged 80 and Above. Scienmag.
